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Summary
Acyl carrier proteins (ACPs) play a fundamental role in
directing intermediates among the enzyme active sites
of fatty acid and polyketide synthases (PKSs). In this
paper, we demonstrate that the Streptomyces coeli-
color (S. coelicolor) actinorhodin (act) PKS ACP can
catalyze transfer of malonate to type II S. coelicolor
fatty acid synthase (FAS) and other PKS ACPs in vitro.
The reciprocal transfer from S. coelicolor FAS ACP to
a PKS ACP was not observed. Several mutations in
both act ACP and S. coelicolor FASACP could be clas-
sified by their participation in either donation or ac-
ceptance of this malonyl group. These mutations indi-
cated that self-malonylation and malonyl transfer
could be completely decoupled, implying that they
were separate processes and that a FAS ACP could
be converted from a non-malonyl-transferring protein
to one with malonyl transferase activity.
Introduction
The acyl carrier protein (ACP) is a fundamental compo-
nent of both fatty acid and polyketide biosynthesis. Its
roles include: shuttling acyl intermediates between the
enzyme active sites of the fatty acid (FAS) and polyke-
tide (PKS) synthases; stabilization of the nascent fatty
acid or polyketide intermediates; and regulation of these
pathways [1–3]. In addition, the acylation of ACP pro-
vides both starter units (e.g., acetyl, propionyl) and 2-
carbon extender units (e.g., malonate) that are required
for priming and chain elongation of fatty acids and poly-
ketides. Malonate is loaded onto the phosphopante-
theine prosthetic arm of the fatty acid ACP by a malonyl
CoA:ACP transacylase (MCAT) [4]. A discrete MCAT has
been identified in type II FAS gene clusters of bacteria
and plants [5, 6], while type I FASs [7] and modular
type I PKSs [8] possess integral acyl transferase (AT)/
MCAT domains. For type II PKSs however, there is no
discrete MCAT located in the gene cluster. This led
*Correspondence: matt.crump@bristol.ac.uk (M.P.C.); john.
crosby@bristol.ac.uk (J.C.)a number of groups to propose that the FAS MCAT is
coopted into polyketide biosynthesis [4, 9]. In 1998,
however, Hitchman et al. demonstrated that PKS ACPs
from a variety of type II bacterial PKSs were subject to
non-MCAT-catalyzed acylation in the presence of ma-
lonyl CoA [10]. This self-catalyzed acylation could also
be extended to other dicarboxylic and b-keto acid thiol
esters, compounds that are not substrates for MCAT
[10, 11].
In addition to self-catalyzed acylation, type II PKS
ACPs have been observed to catalyze the transfer of
malonate to a recipient type II FAS ACP by Reynolds
et al. [12]. Subsequently, however, this observation
was retracted, and previous reports of self-malonylation
and malonyl transfer were attributed to contamination
with theE. coliMCAT (FabD) from theE. coli-based over-
expression systems used [13]. We have, however, re-
cently demonstrated that chemically synthesized Strep-
tomyces coelicolor (S. coelicolor) actinorhodin (act) PKS
ACP self-malonylates in the presence of malonyl CoA.
Since such a chemically synthesized ACP cannot be
contaminated by MCAT, self-acylation must be an inher-
ent enzymic function of this ACP [14]. After confirming
that self-malonylation was an inherent property of poly-
ketide ACPs, we considered it possible that malonyl
transfer was also a genuine enzymatic property of these
carrier proteins.
We now report the observation of malonyl transfer
from type II PKS ACPs to reciprocal PKS or FAS ACPs
and show that this activity is distinct from self-malonyla-
tion. Malonylated type II S. coelicolor FAS ACP is unable
to catalyze transfer to other FAS or PKS ACPs. However,
we have demonstrated that a single mutation can impart
a transferase activity to the previously inactive S. coeli-
color FAS ACP.
Results
In our previous investigations of acylation reactions with
the actinorhodin ACP, we observed that C17 in the wild-
type (WT) ACP rapidly forms an intramolecular disulfide
with the terminal thiol of the phosphopantetheine pros-
thetic group, rendering the ACP inactive [15]. To circum-
vent this, we produced a C17S mutant that showed al-
most identical activity to the WT protein in all other
respects. For this reason, the C17S act ACP has been
used in all of our experiments. We first established
whether act ACP was capable of transferring malonate
to the S. coelicolor FAS holo-ACP (Sc. FAS holo-ACP).
Equimolar concentrations of Sc. FAS holo-ACP and ma-
lonyl CoA were incubated with increasing concentra-
tions of the C17S S. coelicolor actinorhodin holo-ACP
(C17S act holo-ACP) (0, 2, 6, and 10 mM) at 30ºC for 30
min, and the reaction mixture was assayed by electro-
spray mass spectrometry (ESMS). No malonylation of
Sc. FAS holo-ACP was observed in samples lacking
C17S act holo-ACP (Figure 1A), confirming previous ob-
servations that FAS ACPs have no ability to self-malony-
late. When incubated with 2, 6, and 10 mM C17S act holo-
ACP, the extent of malonyl S. coelicolor FAS ACP (Sc.
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588Figure 1. Act ACP-Catalyzed Transfer of a Malonyl Group to Sc. FAS holo-ACP
(A) negative control, (B) 2 mM act ACP, (C) 6 mM act ACP, and (D) 10 mM act ACP. Calculated mass values: (i) Sc. FAS holo-ACP (calculated 9125
Da, observed 9125 6 1 Da), (ii) Sc. FAS mal-ACP (calculated 9211 Da, observed 9210 6 2 Da), (iii) C17S act holo-ACP (calculated 9442 Da,
observed 9440 6 1 Da), and (iv) C17S act mal-ACP (calculated 9525 Da, observed 9527 6 1 Da).FAS mal-ACP) formation was found to be dependent on
the PKS ACP concentration (Figures 1B–1D). When act
ACP was used in the apo form, no malonyl transfer to
Sc. FAS holo-ACP was observed. Converting this apo-
ACP to the holo form by using S. coelicolor holo-acyl
carrier protein synthase (ACPS), however, immediately
restored the acyl transfer ability of the carrier protein.
We have previously shown that S. coelicolor ACPS has
no malonyl transferase activity, confirming that only
holo-ACP is responsible for the observed malonyl trans-
fer activity [14]. Replacing act ACP with another type II
polyketide ACP (either wild-type [no C17S mutation;
WT act holo-ACP] or S. rimosus oxytetracycline holo-
ACP [otc holo-ACP]) [16] or interchanging the FAS
ACP with other FAS ACPs (E. coli or the type I rat ACP
domain) gave similar levels of malonyl transfer (data
not shown). If malonylated S. coelicolor actinorhodin
C17S ACP (C17S act mal-ACP) was preformed by incu-
bation of C17S act apo-ACP with ACPS and malonyl
CoA, followed by gel filtration, then transfer to both
S. coelicolor and E. coli FAS ACPs was also observed.
Transfer was limited to malonate as a substrate.
When acetyl, acetoacetyl, or butyryl act ACPs were
substituted for malonyl ACP, no transfer was observed.
To test for transfer of malonate between polyketide
ACPs, otc and act ACPs were utilized. The self-malony-
lation properties of both polyketide ACPs [10] prevented
the use of malonyl CoA and required that one polyketide
component be preloaded with a malonyl group. In the
first example, WT act mal-ACP was used to transfer its
malonyl group to otc holo-ACP. Again, transfer was
measured by ESMS (Figure 2A). The reciprocal assay
with malonyl otc ACP (otc mal-ACP) and C17S act
holo-ACP is shown in Figure 2B. In both cases, malonyl
transfer was observed between the PKS ACPs giving otc
mal-ACP (55%) and C17S act mal-ACP (65%) relative to
their holo counterparts. Lastly, we used a 15N-labeled
sample of C17S act mal-ACP to investigate transfer of
malonate to unlabeled C17S act holo-ACP. Figure 2C
shows a time course with samples collected at 0, 5,
and 15 min and analyzed by ESMS. At 0 min, 15N C17S
act mal-ACP and C17S act holo-ACP are clearly the pre-
dominant species, although a small amount of 15N C17Sact holo-ACP is present due to cleavage of the thiolester
and loss of malonate. At 5 and 15 min, however, there is
a clear accumulation of C17S act mal-ACP and an in-
crease of 15N C17S act holo-ACP, indicating successful
malonyl transfer.
We next explored whether the type II FAS ACPs were
capable of transferring malonate to another ACP. To test
FAS-to-FAS ACP transfer, preformed Sc. FAS mal-ACP
was incubated with E. coli FAS holo-ACP. ESMS analy-
sis of this reaction revealed no transfer of the malonyl
group (two peaks only observed after 60 min; E. coli
FAS holo-ACP [minus N-terminal methionine] [calcu-
lated 8849 Da, observed 8848 6 2 Da], Sc. FAS mal-
ACP [calculated 9211 Da, observed 9212 6 2 Da]).
Transfer from Sc. FAS mal-ACP to a second Sc. FAS
holo-ACP was also tested. To achieve this, Sc. FAS
mal-ACP was uniformly 15N labeled and therefore distin-
guishable by ESMS. ESMS analysis of this reaction
again revealed no formation of unlabeled Sc. FAS mal-
ACP, confirming that there was no transfer of the ma-
lonyl group (two peaks only observed after 60 min; Sc.
FAS ACP [calculated 9125 Da, observed 9126 6 1 Da],
15N Sc. FAS mal-ACP [calculated 9307 Da, observed
9302 6 2 Da]). When Sc. FAS mal-ACP was incubated
with C17S act holo-ACP (testing FAS-to-PKS ACP trans-
fer), again no transfer of malonate was observed (data
not shown).
When we incubated N-acetylcytsteamine with C17S
act mal-ACP, we found no evidence of transfer from
the protein bound prosthetic group to this free, low-mo-
lecular weight thiol-bearing molecule (data not shown).
We found no evidence of the decrease in the levels of
C17S act mal-ACP over the time course of the experi-
ment, nor did we detect any formation of malonylated
N-acetylcysteamine.
Influence of Point Mutations on the Malonyl
Transferase (Donor) Activity of C17S Act Holo-ACP
To probe the potential role of arginine residues in ACP-
ACP transacylation, R11A, R34A, and R72A mutants of
C17S act ACP were constructed, expressed in E. coli,
and purified. The N79A mutation was also included since
N79 has high sequence conservation in type II PKS
ACP-ACP Acyl Transfer in Type II PKS and FAS ACPs
589ACPs [17]. Successful ACP mutagenesis was confirmed
by DNA sequencing and ESMS (R11A, calculated 9355
Da, observed 9356 6 1 Da; R34A, calculated 9355 Da,
observed 9355 6 1 Da; R72A, calculated 9355 Da, ob-
served 9356 6 2 Da; N79A, calculated 9399 Da, ob-
served 93986 1 Da). Malonyl transferase and self-malo-
nylation activities of all RXA and N79A act ACPs were
established in identical assays to those for act ACP.
With the exception of R72A, the malonyl transfer activity
of all of the above-mentioned mutant ACPs was essen-
tially identical to that of C17S act holo-ACP. The R72A
mutation significantly impaired the ability of the C17S
act holo-ACP to transfer malonate, with only 4% malonyl
Sc. FAS ACP being formed compared to 25% in the
Figure 2. Malonyl Transfer between Polyketide ACPs
(A) Transformed ESMS of WT act mal-ACP incubated with otc holo-
ACP after 30 min.
(B) Transformed ESMS of otc mal-ACP incubated with C17S act
holo-ACP for 30 min. (i) WT act holo-ACP (calculated 9455 Da, ob-
served 9454 6 2 Da). (ii) WT act mal-ACP (calculated 9541 Da,
observed 9541 6 1 Da). (iii) otc holo-ACP (calculated 10256 Da,
observed 10254 6 2 Da). (iv) otc mal-ACP (calculated 10342 Da, ob-
served 10340 6 2 Da). (v) C17S act holo-ACP (calculated 9442 Da,
observed 9440 6 1 Da). (vi) C17S act mal-ACP (calculated 9525 Da,
observed 95256 1 Da). (vii) otc holo-ACP (calculated 10256 Da, ob-
served 10255 6 2 Da). (viii) otc mal-ACP (calculated 10342 Da,
observed 10341 6 2 Da).
(C) Transformed ESMS of 15N act mal-ACP incubated with unla-
beled C17S act holo-ACP.standard act assay over the course of 10 min (Figure 3A).
After 10 min, there was no further increase in malonyl
transfer for the R72A mutant, while C17S act holo-
ACP-catalyzed transfer rose to 40% over the next 50
min. Furthermore, R72A reduced the ability of the ACP
to self-malonylate, giving only 17% malonylation after
10 min compared to 37% for C17S act holo-ACP
(Figure 3B). The remaining mutants underwent self-
malonylation to the maximum extent (40%–50%) after
10 min, but R72A continued to rise slowly, approaching
28% after 60 min.
2D NMR studies were performed to check for struc-
tural perturbations in the R72A C17S act ACP mutant.
Chemical shifts were assigned by using a combination
of 1H-1H 2D TOCSY and NOESY experiments and were
then interpreted by using the chemical shift index (CSI)
[18]. The CSI provides a robust method of interpreting
protein chemical shifts in terms of secondary structure,
particularly when comparing homologous proteins. The
3D structure of WT act apo-ACP and the CSI of WT and
Figure 3. Malonyl Transfer and Self-Malonylation of the C17S
R11A, R34A, R72A, N79A, and Y56A Mutants
(A) Percentage of malonyl transfer to Sc. FAS holo-ACP from ma-
lonyl CoA with PKS ACP mutants.
(B) Percentage of self-malonylation of PKS ACP mutants from ma-
lonyl CoA. The extent of acylation was calculated from the relative
peak areas of the transformed electrospray mass spectra. Assays
were performed in triplicate, and error bars represent 95% confi-
dence intervals.
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pected, the CSI for WT act holo-ACP showed a clear de-
marcation of the four major helices (Figure 4B) [17]. The
CSI for R72A was essentially identical, suggesting a ho-
mologous secondary structure (Figure 4C). The 1H-1H
NOESY spectrum was also used to identify key long
range nOes [17, 19]. All key long-range nOes present in
the WT act holo-ACP spectra could be identified in the
R72A spectrum, suggesting that the detailed 3D struc-
ture was also preserved.
Influence of Point Mutations on the Malonyl
Transferase (Acceptor) Activity of C17S Act
Holo-ACP and Sc. FAS Holo-ACP
A number of studies have suggested that several nega-
tively charged, solvent-exposed amino acids within he-
lix II of FAS ACPs may have important roles in protein-
Figure 4. 3D Structure of WT Act Apo-ACP and Comparison of the
Chemical Shift Indices of Act Apo-ACP Single Point Mutants
(A) Cartoon representation of the 3D structure of WT act apo-ACP.
Helices 1–4 are clearly marked, and residues chosen for mutation
are shown. Ser42, which bears the phosphopantetheine arm in
the holo form of the ACP, is also shown.
(B–D) Comparison of the chemical shift index between (B) WT act
ACP, (C) R72A C17S act ACP, and (D) Y56A C17S act ACP. Consec-
utive helical segments (CSI = 21) are represented as cylinders.protein interactions [20–22]. E47 in act ACP is highly
conserved amongst the type II PKS ACPs, is also situ-
ated on helix II, and is directly analogous to those iden-
tified in the FAS systems. Malonyl transferase and self-
malonylation activities of E47A C17S act ACP were
established by using the same protocols used in mixed
PKS/FAS or PKS/PKS ACP assays. Premalonylated
C17S act ACP could transfer malonylate to E47A C17S
act holo-ACP, but only atw50% of the rate of a control
sample that assayed transfer from 15N C17S act mal-
ACP to C17S act holo-ACP (Figure 5). E47A C17S act
holo-ACP retained the ability to self-malonylate (data
not shown) and could transfer malonate to either FAS
or PKS carrier proteins at the same level as C17S act
holo-ACP (Figure 5). When transfer from C17S act mal-
ACP to E46A Sc. FAS holo-ACP was measured, transfer
was more significantly reduced, yielding only 20% that
of WT Sc. FAS holo-ACP (data not shown) over a 15
min assay. As expected, E46A Sc. FAS holo-ACP did
not self-malonylate and could not transfer malonate to
C17S act or Sc. FAS holo-ACP (data not shown).
Generation of a Malonyl-Transferring FAS ACP
It has been shown previously that the F50A mutation in
Vibrio harveyi FAS ACP led to radical loss of the native
ACP conformation and a reduction in noncovalent acyl
chain binding [22]. We mutated the homologous residue
in act ACP, Y56, to an alanine in order to determine
whether this residue had a similar disruptive effect on
act ACP structure. ACP mutagenesis was confirmed
by DNA sequencing and ESMS (Y56A; calculated 9349
Da, observed 9350 6 1 Da). While Y56A had no effect
on self-malonylation, the ACP’s ability to transacylate
was reduced to one-tenth of control levels (Figures 3A
and 3B). Comparison of the TOCSY and NOESY spectra
for WT and Y56A ACPs showed significant differences,
with helix I curtailed and helices II and IV showing less
helical character (Figure 4D). We also observed the
loss of several key long-range nOes to helix I and con-
comitant loss in helix I/helix IV nOes. Although the 3D
Figure 5. Malonyl Transfer and Acceptance of E47A C17S Act Mal-
ACP and E47A C17S Act Holo-ACP
The extent of acylation was calculated from the relative peak areas
of the transformed electrospray mass spectra. The control C17S
act mal-ACP to C17S act holo-ACP transfer was performed by us-
ing 15N-labeled C17S act mal-ACP. Assays were performed in trip-
licate, and error bars represent 95% confidence intervals.
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591Figure 6. ESMS Analysis of Transfer Ability
of G71R Sc. FAS ACP
Transfer of malonate from G71R Sc. FAS
mal-ACP to Sc. FAS holo-ACP after 0, 5,
15, and 30 min. (i) Sc. FAS holo-ACP (calcu-
lated 9125 Da, observed 9124 6 1 Da). (ii) Sc.
FAS mal-ACP (calculated 9211 Da, observed
9211 6 2 Da). (iii) G71R Sc. FAS holo-ACP
(calculated 9225 Da, observed 9226 6 1 Da).
(iv) G71R Sc. FAS mal-ACP (calculated 9311
Da, observed 9313 6 1 Da).structure is significantly disrupted, the retention of self-
malonylation and the loss of malonyl transfer imply that
these activities can be decoupled. This led us to suggest
that a nontransferring, non-self-malonylating ACP could
be converted to one with either, or both, of these activ-
ities after a predictable mutation. Despite strong se-
quence and structural similarity with the act PKS ACP,
the Sc. FAS ACP (unpublished structure) neither self-
malonylates nor transacylates. Sequence alignment of
this carrier protein with the PKS equivalent identified ho-
mology between G71 of Sc. FAS ACP and R72 of the act
ACP. Thus, the G71R mutation was made in Sc. FAS
ACP, and the protein was expressed, purified, and con-
verted to the holo form. Initially the ability of G71R Sc.
FAS holo-ACP to self-malonylate was assayed. Incuba-
tion of G71R Sc. FAS holo-ACP with an equivalent
amount of malonyl CoA resulted in no observable malo-
nylation of the ACP (data not shown). To test for transfer,
G71R Sc. FAS mal-ACP was formed from G71R Sc. FAS
apo-ACP by using malonyl CoA and ACPS (calculated
9311 Da, observed 9312 6 1 Da). Then, G71R Sc. FAS
mal-ACP and Sc. FAS holo-ACP were incubated to-
gether under standard assay conditions. Analysis by
ESMS showed an approximate 30% transfer of malo-
nate to Sc. FAS holo-ACP over 30 min (calculated 9211
Da, observed 9212 6 2 Da) (Figure 6). This value is
slower than, yet comparable to, transfer by act C17S
holo-ACP.
Discussion
The observation of self-malonylation and malonyl trans-
fer reactions of ACPs provides a possible explanation
for the singular lack of MCAT genes in type II PKS clus-
ters. The recent observation that a chemically synthe-
sized ACP can undergo self-malonylation has reaffirmed
this as a true property of type II PKS ACPs and categor-
ically ruled out the possibility of MCAT contamination.
The discovery of malonyl transfer has also been re-
ported by others [12], although this was subsequently
retracted [13], once again being incorrectly attributed
to MCAT contamination. We have now confirmed thatact ACP does indeed catalyze the transfer of the malo-
nate moiety of malonyl CoA to Sc. FAS holo-ACP and
other type II and type I ACPs; thus, it must also be con-
sidered to be an intrinsic activity of this protein.
The presence of the phosphopantetheine thiol in the
holo form of the ACP is essential for malonyl transfer
and self-malonylation, as neither act C17S apo-ACP
nor free N-acetylcysteamine catalyze either of these pro-
cesses. Conversion of an inactive act C17S apo-ACP to
the holo form by using ACPS restores the acyl transfer
ability of this carrier protein. As with many PKS ACPs,
WT act ACP has a second thiol at position 17, though
substitution of this thiol with a serine had no effect on
the transfer activity. The implication of these findings is
that PKS ACPs may transfer malonate from malonyl
CoA to other ACPs through the process of self-malonyla-
tion followed by transfer to another ACP. We have also
observed that premalonylated PKS ACPs are able to
transfer malonate, indicating that the presence of free
malonyl CoA is not an absolute requirement for catalysis
to occur. Acyl transfer by MCAT shows high substrate
specificity and is limited to malonate. Similarly, acyl
transfer by act C17S ACP shows a similar high substrate
specificity, with malonate being the only acyl group
transferred. In contrast, self-acylation has a more re-
laxed selectivity. Malonyl, methylmalonyl, and acetoace-
tyl CoAs were observed to self-load with high yield,
whereas butyryl and acetyl both failed [10]. A wide range
of b-keto thiolesters in the form of their NAC thioesters
have also been observed to self-acylate [11].
FAS ACPs do not catalyze acyl transfer to either FAS
or PKS ACPs. While act PKS holo-ACP can transfer
a malonyl group to a recipient Sc. FAS holo-ACP, E.
coli FAS holo-ACP, or rat FAS holo-ACP domain, the re-
verse transfer from a FAS ACP to a PKS ACP was not ob-
served. The otc PKS ACP [23], structurally homologous
to act ACP [17], also transferred malonyl to the same
FAS ACPs in a unidirectional fashion. In assays contain-
ing homologous or heterologous type II PKS ACPs, ma-
lonyl transfer is observed to be bidirectional. Thus, PKS
ACPs possess both the ability to donate as well as ac-
cept malonate, while FAS ACPs possess only the ability
Chemistry & Biology
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overall 3D structure of PKS and FAS ACPs may be sim-
ilar, distinct differences between these proteins must
exist. Protein-protein interactions are implicit in the
transfer process. This is confirmed in the experiment in
which the accepting ACP is removed completely and
substituted with only the thiol-bearing N-acetylcyste-
amine. In this case, no malonyl transfer is observed.
There is clearly a donor and acceptor mechanism for
the observed transfer of malonate between acyl carrier
proteins. We chose to investigate the possible role of ar-
ginine residues in the donor mechanism based on high
sequence conservation in PKS ACPs, unusual chemical
shifts of side chain protons [17, 19], and the fact that
these basic residues have been implicated in mediating
protein-protein interactions between E. coli FAS ACP
and several discrete FAS enzymes [24]. When residues
R11, R34, and R72 were mutated to alanine, only the
R72A mutation had any affect on self-malonylation and
malonyl transfer. R72 is 100% conserved in type II PKS
ACPs and is known to be partially buried in the act
[17], fren [25], and otc [23] structures. The possibility
of a significant structural perturbation was discounted
by performing a full NMR chemical shift assignment of
the protein and a 2D 1H-1H NOESY analysis. The role
of R72 in malonyl transfer is not clear. Our results
show that the presence of R72 is important for self-ma-
lonylation and is required for malonyl transfer between
ACPs. We do not understand what the role of this amino
acid is, though R72 may be either involved in docking or
mechanistically in the transfer process. We are currently
conducting additional structure-function studies with
the ACP and other PKS enzymes to identify the full com-
plement of residues involved in molecular recognition,
malonyl transfer, and self-malonylation.
Sc. FAS holo-ACP can act as an acceptor of malonyl
groups, but it cannot catalyze transfer. Since the FAS
protein is able to accept a malonyl group from a polyke-
tide ACP, it must possess the necessary docking site for
the malonyl PKS ACP. Sequence alignment and analysis
of the crystal structure of B. subtilis ACP docked with
ACPS identified a number of acidic residues that may
mediate protein-protein interactions [20]. Introduction
of the E46A mutation into Sc. FAS ACP severely im-
paired its ability to act as an acceptor of malonate, re-
ducing the transfer of this acyl group to the FAS ACP
by 80% over a 30 min assay. The E47A act ACP mutation
had a less significant effect and reduced its ability to ac-
cept transfer of malonate by 50%. This suggests that
these negatively charged residues may form part of
the docking site for ACP-ACP interactions. The fact
that the act E47A mutant only partially reduced transfer
suggests that other residues may be important in ACP-
ACP interactions. The E47A mutant of act ACP retained
the ability to self-malonylate, suggesting that the accep-
tance mechanism and the self-malonylation mechanism
are distinct.
It has been shown previously that the F50A mutation
in Vibrio harveyi FAS ACP led to a significant loss of
the native ACP conformation [22]. Mutating Y56 to ala-
nine in C17S act ACP gave similar structural perturba-
tions and proved crucial in discriminating between
malonyl transfer and self-malonylation. This mutation
resulted in a 10-fold decrease in ACP-catalyzed malonyltransfer over 10 min but had no effect on self-malonyla-
tion, again suggesting that these processes may occur
through different mechanisms centered on separate re-
gions of the protein.
Although self-malonylation and malonyl transfer are
clearly not the same processes, the R72A mutation in
the act ACP system fails to fully distinguish mechanisti-
cally between them. As Sc. FAS holo-ACP can neither
self-malonylate nor transfer, we hypothesized that mak-
ing the reciprocal G71R mutation could transform Sc.
FAS holo-ACP into a protein with one or both of the
self-malonylation or transferase properties of a PKS
ACP. Our experiments demonstrated that the G71R mu-
tation successfully converted a nontransferring Sc. FAS
holo-ACP into one with the ability to transfer malonyl
groups at a rate comparable to act holo-ACP. This muta-
tion, however, did not confer the ability to self-malony-
late to Sc. FAS holo-ACP. This agrees with our muta-
tional data on act ACP that show that R72A only
partially reduced self-malonylation. Clearly, for the act
protein R72 must be only one of several residues impli-
cated in this process. For transfer, however, the intro-
duction of the G71R mutation either provides this single
important residue for theSc. FAS holo-ACP or completes
a set of residues involved in the acyl transfer mechanism.
We have previously published in vitro kinetic parame-
ters for self-malonylation of C17S act holo-ACP (KM =
219 mM, kcat = 0.34 min
21) [10], S. coelicolor MCAT-cat-
alyzed malonyl transfer to S. coelicolor FAS ACP (KM =
73 mM [ACP], 60 mM [malonyl CoA], kcat =450 s
21) [26],
and polyketide turnover by the minimal PKS (maximal
rate of 650 pmol min21 at 200 mM ACP) [27]. The malonyl
transfer we describe in this paper provides in vitro evi-
dence that ACP cannot only select malonyl CoA, but
can also specifically transfer these malonyl groups
(albeit at a rate several orders of magnitude slower
than the MCAT). Thus, in an in vitro situation ACP acts
as a malonyl transferase and is all that is required to
produce polyketides in the presence of the other mini-
mal components, KSa and KSb.
The alternative to the lack of an MCAT gene is for S.
coelicolor act PKS to recruit MCAT from FAS. Enzyme
assays have suggested that MCAT levels can be deter-
mined during the growth and stationary phases of S.
coelicolor, implying that MCAT may be present during
polyketide biosynthesis [4]. These are, however, whole
cell homogenates and do not indicate any subcellular
compartmentalization that may be occurring and would
prevent such enzyme crosstalk. Subsequently, how-
ever, extensive proteomic analysis of S. coelicolor dur-
ing the stationary growth phase failed to detect MCAT
[28, 29]. The work described in this paper addresses
the lack of an MCAT gene in the PKS cluster and sug-
gests that the malonyl transfer ability of an ACP could
substitute for the lack of an MCAT enzyme, albeit at
a much lower rate. This in vitro work may shed some
light on the in vivo mechanism of polyketide production
by the minimal PKS.
Significance
Despite similar overall 3D structures, the PKS and FAS
type II acyl carrier proteins are required to transport
very different chemical intermediates, interact with
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593Figure 7. Schematic Representation of Type II Polyketide Biosynthesis in the Absence of MCAT
The minimal PKS (KS [purple], CLF [blue], and bound ACP [green]) interacts with free malonylated ACP (yellow). Progressing clockwise, mal-
onate required for starter unit generation and chain elongation is continuously supplied to the bound ACP from a pool of free malonyl ACP.different PKS or FAS components, and have a limited
capacity to substitute for one another in vivo [30]. In
addition, only PKS ACPs can undergo self-malonyla-
tion [10]. In this report, we have shown that these dif-
ferences extend to another property, self-catalyzed
malonyl transfer. Malonyl transfer is clearly a property
of act ACP, though there remains the question of
whether ACP-ACP malonyl transfer plays any role in
polyketide production in vivo. In vitro we have shown
that the minimal PKS consisting of just KSa/KSb and
ACP is sufficient for polyketide production, and that
if transfer occurs it does so fast enough to sustain
this process [27]. The requirement for a continuous
supply ofmalonyl ACP, the lack of a discreteMCAT an-
alog, and the need to sequester a growing polyketide
chain does therefore suggest several mechanistic
possibilities. In the absence of a discrete malonyl
transferase enzyme, the ACP-ACP transacylase activ-
ity may substitute for a dedicated malonyl transferase.
In a previously proposed model for polyketide biosyn-
thesis in the act minimal system [31], a priming ma-
lonyl ACP is first decarboxylated by KSb to give acetyl
ACP [32]. The ACP then translocates to KSa and, once
bound, delivers the acetyl group to the KSa cysteine
thiol. This ACP may then remain associated with the
KSa, and a second malonyl ACP binds to the complex
and transfers its malonyl group to the bound ACP. The
bound ACP remains associated with the KSa through
the first and subsequent rounds of decarboxylative
condensation, being continually fed by ACP-ACP ma-
lonyl transfer (Figure 7). Such a mechanism eliminates
the necessity for at least one of the ACPs to dissociate
from the polyketide synthase complex, and by main-
taining this complex, aberrant cyclization of the grow-
ing polyketide chain may be prevented [33].Experimental Procedures
Chemical and Microbiological Reagents
Unless otherwise stated all chemicals were purchased from Sigma-
Aldrich, UK. E. coli strains BL21 (DE3) and XL1-Blue were purchased
from Novagen, Nottingham, UK and Stratagene, Cedar Creek, USA,
respectively.
Protein Preparation and Purification
ACPs were expressed and purified by following the method of
Crosby et al. [34]. The C17S mutant of act ACP was utilized in all
of the in vitro PKS assays involving act ACP, as it has been shown
that WT act holo-ACP can form an intramolecular disulphide bridge
between the phosphopantetheine thiol and the thiol group of C17
[35]. ACPS was expressed and purified by following the method of
Cox et al. [15]. Ketosynthase dimer (KSa/KSb) was purified as previ-
ously reported [27]. Where required, phosphopantetheinylation of
apo-ACP to yield holo-ACP was achieved by incubation of purified
apo-ACP (100 mM) with ACPS (1 mM) and coenzyme A (1 mM) in
the presence of dithiothreitol (DTT, 5 mM, Melford Laboratories,
Ltd., Ipswich, UK), MgCl2 (10 mM), and Trizma base (TRIS-Cl, 50
mM [pH 8.8]) [36]. Reactions were incubated at 30ºC for 16 hr, and
apo- to holo-ACP conversion was confirmed by ESMS. Prior to
use, stock ACP samples (500 mM) were reduced and monomerized
with DTT for 16 hr at 30ºC.
Preparation of Acyl ACPs
(1) Acetyl ACP was prepared by using C17S act holo-ACP (500 mM),
EDTA (1 mM), N-acetyl imidazolide (4 mM), and potassium phos-
phate buffer (50 mM, pH 7.0). The reaction was stopped after 30
min, desalted into MilliQ water, and lyophilized. Formation of acetyl
ACP was monitored by ESMS. (2) Malonyl ACP was prepared by us-
ing C17S act holo-ACP (500 mM) and malonyl CoA (5 mM) in potas-
sium phosphate buffer (50 mM [pH 7.0]) and incubating for 6 hr. (3)
Acetoacetyl ACP was prepared by using C17S act holo-ACP (500
mM), acetoacetyl N-acetylcysteamine (SNAC) thiolester [37] (30
mM), and potassium phosphate buffer (50 mM). (4) Butyryl ACP
was prepared by using C17S act apo-ACP (500 mM), ACPS (0.25
mM), butyryl coenzyme A (750 mM), MgCl2 (10 mM), and TRIS-Cl
(50 mM [pH 8.8]). The conversion was carried out at 30ºC for 16 hr.
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594E. coli FAS holo-ACP (Sigma-Aldrich) was purified by anion ex-
change chromatography and treated with ammonium hydroxide
(0.2 M [pH 7.0]) for 4 hr at 30ºC to remove any acyl adducts. Where
required, ACP was labeled with 15N by expression in M9 minimal me-
dia containing 15N ammonium chloride as the sole source of nitrogen
[15]. The ACP was purified by using standard techniques described
above, and the percentage of label incorporated was determined by
ESMS to be greater than 97%.
Electrospray Mass Spectrometry
Protein ESMS was performed in positive ion mode on a Fison’s In-
struments VG Quattro triple quadrupole mass spectrometer at-
tached to a Jasco PU-980 Intelligent HPLC Pump operating at a 30
ml/min flow rate and a 50:50 v/v mixture of water and acetonitrile
as the running solvent. Unless otherwise stated, all assays were
quenched by mixing with C4 resin (Jupiter C4 100 A˚, Phenomenex)
in methanol and desalted prior to ESMS according to the method de-
scribed by Winston and Fitzgerald [38].
Malonyl Transfer Activity of PKS and FAS ACPs
The effect on malonyl transfer of increasing amounts of C17S act
holo-ACP was assayed by using Sc. FAS holo-ACP (50 mM), C17S
act holo-ACP (0, 2, 6, 10 mM), DTT (0.1 mM), malonyl CoA (50 mM),
and potassium phosphate buffer (50 mM [pH 7.0]). The mixture
was incubated in a final volume of 50 ml for 30 min at 30ºC and
then quenched as described above. For the control reactions, iden-
tical assays were carried out in which C17S act holo-ACP was re-
placed with C17S act apo-ACP. In order to confirm the malonyl
transfer ability of holo-ACP, C17S act apo-ACP used in these control
experiments was then converted to the holo form by using ACPS
(described above), and the assay was repeated to test for restora-
tion of malonyl transfer. In addition assays, were performed in which
C17S act holo-ACP was substituted with WT act holo-ACP (no C17S
mutation) and otc holo-ACP. Sc. FAS holo-ACP was also substituted
with either the rat FAS holo-ACP domain or E. coli FAS holo-ACP. In
these assays and those incorporating point mutations, the following
reagents were used: standard FAS ACP (50 mM), DTT (0.1 mM), ma-
lonyl CoA (50 mM), and PKS ACP (1 mM), all in potassium phosphate
buffer (50 mM [pH 7.0]) in a final volume of 50 ml. The assays were in-
cubated at 30ºC for 15 or 30 min and then quenched. Assays were
performed in triplicate.
Malonyl Transfer Ability of Malonyl S. coelicolor FAS ACP
Sc. FAS mal-ACP was first prepared by using Sc. FAS apo-ACP (50
mM), ACPS (1 mM), malonyl CoA (500 mM) in TRIS-HCl (50 mM [pH
8.8]) and MgCl2 (10 mM) buffer. The reaction was incubated at
30ºC for 2 hr, at which point the reaction was desalted into MilliQ wa-
ter, flash frozen, and lyophilized. ESMS of the sample indicated
a small amount of Sc. FAS holo-ACP, which was removed by allow-
ing the holo-ACP to covalently dimerize and then by utilizing size ex-
clusion column chromatography. Sc. FAS mal-ACP (50 mM) was then
incubated with monomerized C17S act holo-ACP (50 mM) in potas-
sium phosphate buffer (50 mM [pH 7.0], 50 ml) for 15 min at 30ºC.
C17S act holo-ACP was also substituted with E. coli FAS holo-
ACP and 15N-labeled Sc. FAS holo-ACP.
Malonyl Transfer between PKS ACPs
Typical assays contained act WT or otc mal-ACP (50 mM) incubated
with monomerized otc or C17S act holo-ACP (50 mM), respectively,
in potassium phosphate buffer (50 mM [pH 7.0], 50 ml) for 30 min at
30ºC. Reactions were quenched and analyzed by ESMS. The trans-
fer of malonate from one molecule of act ACP to another was mon-
itored by observing the transfer of malonate from 15N C17S act mal-
ACP to unlabeled C17S act holo-ACP.
Transfer of Other Acyl Groups between ACP Species
Sc. FAS holo-ACP (50 mM) and C17S act acyl ACP (10 mM) were in-
cubated together for up to 2 hr in potassium phosphate buffer
(50 mM, 50 ml [pH 7.0]) and then quenched. Displacement of acetyl/
butyryl groups by malonyl CoA was assayed by incubating act
acetyl/butyryl ACP (50 mM), malonyl CoA (1 mM), and potassium
phosphate buffer (50 mM, 50 ml [pH 7.0]) for 2 hr at 30ºC.Transfer of Acyl Groups between C17S Act Malonyl ACP
and N-Acetylcysteamine
C17S act mal-ACP (50 mM) was incubated with N-acetylcysteamine
(50 mM) in potassium phosphate buffer (50 mM [pH 7.0], 50 ml) for 30
min at 30ºC. Reactions were quenched and analyzed by ESMS to de-
tect malonylated N-acetylcysteamine and an increase in C17S act
holo-ACP.
Site-Directed Mutagenesis and Expression of Act R11A, R34A,
and R72A ACP Mutants
Divergent polymerase chain reaction (PCR) was carried out by using
pRJC001 [15] (coexpressing the C17S act ACP and E. coli ACPS in
the plasmid pT7-7). PCR reactions were carried out by using VENT
proof-reading polymerase under the following conditions (anneal-
ing, elongation, denaturing): R11A: 96ºC, 60 s; 65ºC, 75 s; 72ºC,
165 s; R34A: 96ºC, 60 s; 63ºC, 60 s; 72ºC, 180 s; R72A: 96ºC, 60 s;
65ºC, 75 s; 72ºC, 165 s, for 20 cycles in each case. Purified DNA
was digested with DpnI and transformed into E. coliDH5a. Individual
clones were selected, and their plasmid DNA was isolated and se-
quenced. R11A and R34A act ACPs were expressed in the holo
form from E. coli K38 pGP1-2 [39]. R72A act ACP was ligated into
pET11c vector and was expressed in the apo form in E. coli BL21
(DE3). The resultant apo protein was converted to the holo form by
using ACPS as described previously [15].
Cloning and Expression of S. coelicolor Y40A, E47A, Y56A,
and N79A of C17S ACPs and G71R and E46A Sc. FAS ACPs
Site-directed mutagenesis of act ACP was performed on plasmid
pCJAI159/1F (a coexpression plasmid encoding for act ACP and
E. coli ACPS [40]) by using the QuikChange site-directed mutagen-
esis kit (Stratagene) following the manufacturer’s protocol. The oli-
gonucleotide primers (Table S1; see the Supplemental Data avail-
able with this article online) were synthesized (Lark Technologies,
Cambridge) and purified by polyacrylamide gel electrophoresis.
dsDNA template (50 ng) was used as standard. The plasmids iso-
lated from XL1-Blue were transformed into E. coli BL21 (DE3) and
maintained as suspensions in 20% glycerol at 280ºC. Proteins
were expressed and purified as described above. Site-directed mu-
tagenesis of Sc. FAS ACP was performed on plasmid pIJ8130 (a
pET-based expression plasmid encoding for Sc. FAS ACP).
Effect of G71R Mutagenesis on Malonyl Transfer
Typical assays contained G71R Sc. FAS mal-ACP (25 mM) incubated
with reduced Sc. FAS holo-ACP (25 mM) in potassium phosphate
buffer (50 mM [pH 7.0]) at 30ºC in a total volume of 50 ml. Assays
were quenched at 0, 5, 15, and 30 min and were analyzed by ESMS.
NMR Analysis of Y56A and R72A Act ACPs
All NMR spectra were collected on a Varian INOVA 600 MHz spec-
trometer. Standard COSY, NOESY, and TOCSY data sets were ac-
quired and compared to the equivalent 2D data sets for WT act
apo-ACP [19].
Supplemental Data
Supplemental Data include a table detailing oligonucleotides used
for site-directed mutagenesis and are available at http://www.
chembiol.com/cgi/content/full/13/6/587/DC1/.
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